Cadila gets final USFDA approval to market Deferasirox tablets
Cadila gets final USFDA approval to market Deferasirox tablets

Cadila gets final USFDA approval to market Deferasirox tablets

Nidhi Jani Article rating: 4.1

The company has received USFDA nod to market Deferasirox tablets (90 mg, 180 mg and 360 mg), which is used for treating high levels of iron in patients, having a certain blood disorder.

COVID-19 affects May exports adversely; exports plunge 36 per cent
COVID-19 affects May exports adversely; exports plunge 36 per cent

COVID-19 affects May exports adversely; exports plunge 36 per cent

Nidhi Jani Article rating: 5.0

However, the drop in exports during the month under review is low as compared to 60.28 per cent fall in April 2020. Trade deficit, gap between imports and exports, narrowed to US$ 3.15 billion in May 2020 from US$ 15.36 billion a year ago.

Alembic Pharmaceutical touches 52-week high, gets fresh USFDA approval
Alembic Pharmaceutical touches 52-week high, gets fresh USFDA approval

Alembic Pharmaceutical touches 52-week high, gets fresh USFDA approval

Pratik Shastri Article rating: 5.0

The IQVIA, a US-based company, which is engaged in serving as the information and database provider of the healthcare industry, stated that Deferasirox Tablets, 180 mg, has an estimated market size of US$ 53 million (Rs 400 crore approximately).

GlobalSpace Technologies gains popularity in STEAM education space
GlobalSpace Technologies gains popularity in STEAM education space

GlobalSpace Technologies gains popularity in STEAM education space

DSIJ Intelligence Article rating: 3.9

The EduTech subsidiary, Makebot Robotic Solutions Pvt Ltd of GlobalSpace is surfacing as a leader in STEAM education using robotics, artificial intelligence (AI), internet of things (IOT) platforms for all the students across K-12.

Ind-Swift Lab gets ready to launch new API in US markets
Ind-Swift Lab gets ready to launch new API in US markets

Ind-Swift Lab gets ready to launch new API in US markets

Nidhi Jani Article rating: 3.3

Speaking only of US, the revenue contribution stands at approximately 14 per cent and the company delivers seven to eight products to the US markets. This new API launch would be a different opportunity for the company as US is a significant market for Fexofenadine.

Gap-up opening for markets!
Gap-up opening for markets!

Gap-up opening for markets!

DSIJ Intelligence-3 Article rating: 5.0

The announcement from US Fed to purchase individual corporate debt is likely to boost the sentiment on the Dalal Street. Early trends on SGX Nifty suggests that bulls are likely to hit a double century at the opening bell. At 7:51 am, SGX Nifty was trading up by 1.97 per cent at 9,889.50 levels.

Index trend and stocks in action on June 16, 2020
Index trend and stocks in action on June 16, 2020

Index trend and stocks in action on June 16, 2020

DSIJ Intelligence-3 Article rating: 3.5

The level of 9,700 and 9,640 is likely to be a strong support zone for the index and on the upside, Friday’ session high of 9,996 is likely to act as a strong barrier on the upside. Stocks in news: SBI Cards and Payment Services Limited, Ind-Swift Laboratories, Wipro.

Tata Power arm obtains 120 MW solar project order from GUVNL
Tata Power arm obtains 120 MW solar project order from GUVNL

Tata Power arm obtains 120 MW solar project order from GUVNL

DSIJ Intelligence Article rating: 3.8

On Monday, Tata Power declared that its renewable energy arm, Tata Power Renewable Energy Limited (TPREL) received a letter of award (LoA) from Gujarat Urja Vikas Nigam Limited (GUVNL) to construct a 120 MW solar project in the state of Gujarat, India.

RSS
First29612962296329642966296829692970Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR